Cage Pharmaceuticals, Inc.

New Filing
CIK: 0001727073·Other Health Care·DELAWARE·Filed: Jul 12, 2019
Total Offering

$480,000

Amount Sold

$480,000

Investors

1

First Sale

Jul 10, 2019

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
Jason Rifkin
Related Person

Company

Cage Pharmaceuticals, Inc.

500 E. PRATT STREET

BALTIMORE, MD, 21202

917-733-1542

SEC Filing

0001727073-19-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cage Pharmaceuticals, Inc. Form D Filing — $480,000 | FilingFlow